№ files_lp_3_process_7_093052
File format: docx
Character count: 2557
File size: 42 KB
Year:
Not specified
Region / City:
Not specified
Topic:
Pharmaceutical products, Drug validation
Document type:
Checklist
Organization / Institution:
MDA (Malaysian Drug Authority)
Author:
Not specified
Target audience:
Pharmaceutical companies, regulatory authorities
Validity period:
Not specified
Approval date:
Not specified
Amendment date:
Not specified
Language:
English
Keywords:
Drug product, Biologics, Validation, Pharmaceutical, Medical device
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Note:
Year
Subject:
Pharmaceutical Quality Information Summary
Document Type:
Template
Agency / Institution:
SAHPRA
Note:
Year
Theme:
Data Integrity, Pharmaceutical Industry, Biologics
Document type:
Code of Conduct
Organization / institution:
Parenteral Drug Association (PDA)
Author:
Parenteral Drug Association (PDA)
Target audience:
Pharmaceutical and Biologics Industry Professionals
Year:
2018
Region / City:
Fredericksburg, VA
Topic:
Biologics, Contracting, Medical Supplies
Document Type:
Contract Award Notice
Agency:
U.S. Department of Veterans Affairs
Author:
Not specified
Target Audience:
Contractors, Veterans Affairs
Period of Action:
From September 27, 2018
Approval Date:
September 27, 2018
Date of Changes:
Not specified
Year:
2023
Region / City:
Oxon Hill, Maryland
Topic:
Biologics, Biotechnology, Veterinary Health
Document Type:
Meeting Minutes
Organization:
USAHA Committee on Biologics and Biotechnology
Author:
Committee members and speakers
Target Audience:
Veterinary professionals, industry representatives, regulatory bodies
Period of Activity:
October 17, 2023
Approval Date:
October 17, 2023
Date of Changes:
Not indicated
Year:
2013
Region / City:
EU
Subject:
Biologics, Biotechnology, Clinical Trials, Market Authorization
Document Type:
Clinical Trial and Market Authorization Process Overview
Organization:
NCL Innovations
Author:
NCL Innovations
Target Audience:
Healthcare professionals, regulatory bodies, pharmaceutical companies
Period of Validity:
Not specified
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2026
Region / City:
Not specified
Document Type:
Patient Directive / Legal Statement
Institution:
Hospital or affiliated medical facility
Author:
Patient (name not specified)
Target Audience:
Medical staff, legal representatives
Date of Document:
2026-03-06
Purpose:
To formally refuse vaccines, biologics, and biogenics during hospitalization
Method of Consent:
Signed by patient in presence of witnesses
Notarization:
Optional, recommended for legal validation
Year:
2025
Document Type:
Worksheet
Purpose:
Emergency use of unapproved drugs, biologics, or devices
Audience:
Investigators and Designated Reviewers
Regulatory Reference:
FDA IND, 21 CFR §50
Scope:
Life-threatening or severely debilitating conditions
Approval Requirement:
IRB reporting within 5 working days
Consent Requirement:
Informed consent from patient or legally authorized representative, exceptions documented
Certification:
Physician uninvolved in investigation must certify when consent cannot be obtained
Document ID:
HRP-322
Related Documents:
HRP-310, HRP-314, HRP-506
Year:
2016
Region / City:
United States
Topic:
Pharmacy Information Management
Document Type:
Technical Requirement
Organization / Institution:
Veterans Health Administration (VHA)
Author:
Veterans Health Administration
Target Audience:
Vendors, Pharmaceutical Suppliers, IT Developers
Period of Validity:
From January 18, 2017
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2019
Region / City:
United States
Topic:
Information Technology, Veterans Affairs, Healthcare
Document Type:
Performance Work Statement
Agency / Institution:
Department of Veterans Affairs, Office of Information & Technology
Author:
Not specified
Target Audience:
Contractors, VA staff, IT professionals
Period of Effectiveness:
June 27, 2019, onwards
Approval Date:
June 27, 2019
Amendments Date:
Not specified
Year:
2025
Region / City:
Louisiana
Topic:
Alcohol and Drug Survey
Document Type:
Guidelines
Organization / Institution:
Louisiana Board of Regents
Author:
Dr. Allison Smith
Target Audience:
IRB administrators, researchers, university staff
Period of Validity:
2025
Approval Date:
October 4, 2024
Amendment Date:
November 15, 2024
Note:
Year
Subject:
Emergency Use Treatment
Document Type:
Informed Consent Form
Year:
2025
Jurisdiction:
Washington State
Topic:
Drug supply chain security and pharmacy regulatory compliance
Document type:
Self-inspection worksheet
Issuing body:
Washington State Pharmacy Quality Assurance Commission
Governing law:
Drug Supply Chain Security Act (DSCSA); RCW 18.64.026; WAC 246-945
Applicable entities:
Drug manufacturers; wholesale distributors; dispensers
Regulatory scope:
State and federal pharmacy law
Compliance status:
Optional addendum with mandatory DSCSA compliance
Intended role:
Responsible pharmacy manager or equivalent manager
Retention requirement:
Kept on file; not submitted to the commission
Source type:
Government regulatory document
Year:
2023
Region / City:
Australia
Subject:
Aboriginal Alcohol and Other Drug Rehabilitation
Document Type:
Report
Organization / Institution:
National Indigenous Australians Agency (NIAA)
Author:
Shakeshaft A, Clifford-Motopi A, Doran C, Tranh A, Nalukwago S, Henderson N, Coyte J, Edwards D, Stacey T, Gordon T, Bennett A, Lee A
Target Audience:
Researchers, Policy Makers, Healthcare Providers
Effective Period:
Not specified
Approval Date:
Not specified
Amendment Date:
Not specified
Copyright:
Commonwealth of Australia, 2023
ISBN:
978-1-925365-17-7
Note:
Description
Year:
2019
Region / City:
Ghana
Topic:
Pharmaceutical registration
Document Type:
Application Form
Organization / Institution:
Food and Drugs Authority
Author:
Food and Drugs Authority
Target Audience:
Pharmaceutical companies, healthcare professionals, regulatory bodies
Period of Validity:
Not specified
Date of Adoption:
1st August 2019
Date of Issue:
1st September 2019
Date of Changes:
Not specified
Year:
(not specified)
Region / City:
(not specified)
Theme:
Drug Court, Treatment, Criminal Justice
Document Type:
Memorandum of Understanding
Organ / Institution:
(not specified)
Author:
(not specified)
Target Audience:
Judicial and law enforcement personnel, treatment providers
Period of validity:
(not specified)
Date of approval:
(not specified)
Date of changes:
(not specified)
Note:
Contextual description
Note:
Year
Jurisdiction:
State of Wisconsin
Issuing body:
Wisconsin Department of Health Services
Division:
Division of Medicaid Services
Program:
ForwardHealth
Legal reference:
Wis. Admin. Code § DHS 107.10(2)
Form number:
F-01430
Form version date:
December 2021
Document type:
Prior authorization medical form
Subject matter:
Prescription authorization for Xyrem and Xywav
Medical conditions referenced:
Narcolepsy with cataplexy, narcolepsy without cataplexy, idiopathic hypersomnia
Intended users:
Prescribers and pharmacy providers
Required attachments:
Medical records, sleep study results, ESS, MWT, MSLT
Regulatory requirement:
Xyrem and Xywav REMS Program compliance
Signature requirement:
Prescriber signature and date
Year:
2022
Region / city:
Victoria, Australia
Topic:
Mental health, substance use, addiction
Document type:
Guidance
Institution:
Victorian Government, Department of Health
Author:
Victorian Government
Target audience:
Mental health and wellbeing and alcohol and other drug service providers
Period of validity:
Not specified
Approval date:
July 2022
Revision date:
Not specified
Year:
2015
Region / City:
Chicago
Theme:
Health insurance, public sector
Document type:
Request for Proposal (RFP)
Organ / Institution:
City of Chicago, Chicago Park District, Chicago Public Schools
Author:
City of Chicago Department of Finance
Target audience:
Organizations with experience in HMO and/or Prescription Drug solutions
Period of validity:
January 1, 2016 - (contract term)
Approval date:
Not specified
Amendment date:
Not specified